[2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]
- PMID: 23849214
- DOI: 10.1016/j.arteri.2013.03.002
[2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]
Abstract
Correlation between systolic (SBP) and diastolic (DBP) blood pressure (BP) level and target organ damage, cardiovascular disease (CVD) risk, and long-term prognosis is much greater for ambulatory BP monitoring (ABPM) than daytime office measurements. The 2013 ABPM guidelines specified herein are based on ABPM patient outcomes studies and constitute a substantial revision of current knowledge. The asleep SBP mean and sleep-time relative SBP decline are the most significant predictors of CVD events, both individually as well as jointly when combined with other ABPM-derived prognostic markers. Thus, they should be preferably used to diagnose hypertension and assess CVD and other associated risks. Progressive decrease by therapeutic intervention in the asleep BP mean is the most significant predictor of CVD event-free interval. The 24 h BP mean is not recommended to diagnose hypertension because it disregards the more valuable clinical information pertaining to the features of the 24 h BP pattern. Persons with the same 24 h BP mean may display radically different 24 h BP patterns, ranging from extreme-dipper to riser types, representative of markedly different risk states. Classification of individuals by comparing office with either the 24 h or awake BP mean as "masked normotensives" (elevated clinic BP but normal ABPM), which should replace the terms of "isolated office" or "white-coat hypertension", and "masked hypertensives" (normal clinic BP but elevated ABPM) is misleading and should be avoided because it disregards the clinical significance of the asleep BP mean. Outcome-based ABPM reference thresholds for men, which in the absence of compelling clinical conditions are 135/85 mmHg for the awake and 120/70 mmHg for the asleep SBP/DBP means, are lower by 10/5 mmHg for SBP/DBP in uncomplicated, low-CVD risk, women and lower by 15/10 mmHg for SBP/DBP in male and female high-risk patients, e.g., with diabetes, chronic kidney disease (CKD), and/or past CVD events. In the adult population, the combined prevalence of masked normotension and masked hypertension is >35%. Moreover, >20% of "normotensive" adults have a non-dipper BP profile and, thus, are at relatively high CVD risk. Clinic BP measurements, even if supplemented with home self-measurements, are unable to quantify 24 h BP patterning and asleep BP level, resulting in potential misclassification of up to 50% of all evaluated adults. ABPM should be viewed as the new gold standard to diagnose true hypertension, accurately assess consequent tissue/organ, maternal/fetal, and CVD risk, and individualize hypertension chronotherapy. ABPM should be a priority for persons likely to have a blunted nighttime BP decline and elevated CVD risk, i.e., those who are elderly and obese, those with secondary or resistant hypertension, and those diagnosed with diabetes, CKD, metabolic syndrome, and sleep disorders.
Keywords: Blood pressure monitoring; Cardiovascular risk; Chronotherapy in hypertension; Clinical guidelines for carrying out ambulatory blood pressure monitoring; Cronoterapia en la hipertensión; Guías clínicas para la realización de monitorización ambulatoria de la presión arterial; Hipertensión enmascarada; Hipertensión verdadera; Masked hypertension; Masked normal blood pressure; Monitorización ambulatoria de la presión arterial; Nocturnal blood pressure; Normotensión enmascarada; Presión arterial nocturna; Riesgo cardiovascular; True hypertension.
Copyright © 2013 Elsevier España, S.L. y SEA. All rights reserved.
Similar articles
-
2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.Chronobiol Int. 2013 Apr;30(3):355-410. doi: 10.3109/07420528.2013.750490. Chronobiol Int. 2013. PMID: 23517220
-
Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.Chronobiol Int. 2013 Mar;30(1-2):207-20. doi: 10.3109/07420528.2012.701135. Epub 2012 Oct 19. Chronobiol Int. 2013. PMID: 23077975 Clinical Trial.
-
Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.Chronobiol Int. 2013 Mar;30(1-2):87-98. doi: 10.3109/07420528.2012.701127. Epub 2012 Oct 5. Chronobiol Int. 2013. PMID: 23039824 Clinical Trial.
-
Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention.Sleep Med Rev. 2017 Jun;33:17-27. doi: 10.1016/j.smrv.2016.04.001. Epub 2016 Apr 14. Sleep Med Rev. 2017. PMID: 27316324 Review.
-
Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk.Eur J Clin Invest. 2018 May;48(5):e12909. doi: 10.1111/eci.12909. Epub 2018 Feb 25. Eur J Clin Invest. 2018. PMID: 29423914 Review.
Cited by
-
The B-Score is a novel metric for measuring the true performance of blood pressure estimation models.Sci Rep. 2022 Jul 16;12(1):12173. doi: 10.1038/s41598-022-16527-2. Sci Rep. 2022. PMID: 35842524 Free PMC article.
-
Ambulatory diastolic blood pressure: a marker of comorbidity in elderly fit hypertensive individuals?J Geriatr Cardiol. 2022 Apr 28;19(4):254-264. doi: 10.11909/j.issn.1671-5411.2022.04.009. J Geriatr Cardiol. 2022. PMID: 35572223 Free PMC article.
-
Chronoprevention in hospital falls of older people: protocol for a mixed-method study.BMC Nurs. 2021 Jun 6;20(1):88. doi: 10.1186/s12912-021-00618-y. BMC Nurs. 2021. PMID: 34092223 Free PMC article.
-
The potential role of testosterone in hypertension and target organ damage in hypertensive postmenopausal women.Clin Interv Aging. 2019 Apr 29;14:743-752. doi: 10.2147/CIA.S195498. eCollection 2019. Clin Interv Aging. 2019. PMID: 31118595 Free PMC article.
-
Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm.Neonatology. 2017;112(1):87-91. doi: 10.1159/000464243. Epub 2017 Apr 12. Neonatology. 2017. PMID: 28399534 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous